Despite the clear relevance of genetic aberrations in human breast cancer progression and the wide use of mouse models to study human breast cancer in vivo, relatively few mouse models of breast cancer have been characterized at the genome level, barring MMTV-PyMT [27, 28], MMTV-Neu [27], and NRL-PRL [29] models. This evidence concerns the gene PRL and breast cancer.